Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.54 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.54 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.54 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | PYGB | P11216 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ribose (Furanose) SCHEMBL15814845 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL14349491 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL16199379 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL24087736 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL66645 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL23017520 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL109435 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL12878699 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL7618455 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA | |
| Ribose (Furanose) SCHEMBL13135754 | 1.00 | LGALS1 (0.54) | LGALS1LGALS3LGALS9LGALS8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 999 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121005799-B | Application of uncaria neutral polysaccharide URP-W in preparation of glioma resistant drugs | CHANGCHUN UNIVERSITY OF CHINESE MEDICINE (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122080245-A | Novel polysaccharide extracted from dark plum fruit, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122036983-A | Nine-steaming nine-preparation rhizoma polygonati uniform polysaccharide and preparation method and application thereof | 黑龙江省中医药科学院 | 2026-05-15 | — | — | CN | claimed |
| CN-122036977-A | Tibetan angelica uniform polysaccharide and preparation method and application thereof | 陕西中医药大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122036980-A | Uniform polysaccharide, preparation method thereof and application thereof in improving glycolipid metabolic disorder | 浙江中医药大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122011233-A | Ampelopsis polysaccharide, preparation method thereof and application of Ampelopsis polysaccharide in preparation of colorectal cancer therapeutic drugs | 浙江工业大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4701656-A1 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | Pfizer Inc. (US) | 2026-03-04 | — | — | EP | claimed |
| US-20250302947-A1 | M-cell GP2-mediated lymphatic-targeted drug carriers | HONG KONG BAPTIST UNIVERSITY (CN) | 2025-10-02 | — | — | US | claimed |
| CN-120157783-A | Litchi chitin and extraction method and application thereof | 贵州中医药大学 | 2025-06-17 | — | — | CN | claimed |
| CN-117467031-B | Lalang grass rhizome acidic polysaccharide, preparation method and application | 东北林业大学 | 2025-05-27 | — | — | CN | claimed |
| US-20040063612-A1 | Neuroprotective agents | CARBOMER, INC. | 2004-04-01 | — | — | US | claimed |
| EP-1373288-A1 | PROCESS FOR THE PREPARATION OF 2'-HALO-BETA-L-ARABINOFURANOSYL NUCLEOSIDES | Triangle Pharmaceuticals Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| US-20030060622-A1 | Process for the preparation of 2'-halo-beta-L-arabinofuranosyl nucleosides | BUKWANG PHARMACEUTICAL IND CO., LTD. (KR) | 2003-03-27 | — | — | US | claimed |
| WO-2002079213-A1 | PROCESS FOR THE PREPARATION OF 2'-HALO-$G(B)-L-ARABINOFURANOSYL NUCLEOSIDES | TRIANGLE PHARMACEUTICALS, INC. (US) | 2002-10-10 | — | — | WO | claimed |
| WO-1999006584-A1 | THERMOSTABLE ALPHA-L-ARABINOFURANOSIDASE FROM AUREOBASIDIUM PULLULANS | THE UNITED STATES OF AMERICA REPRESENTED BY THE (US) | 1999-02-11 | — | — | WO | claimed |
| EP-0475383-B1 | Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient | NISSHIN SPINNING (JP) | 1995-12-06 | — | — | EP | claimed |
| US-5268366-A | Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient | NISSHINBO INDUSTRIES, INC. (JP) | 1993-12-07 | — | — | US | claimed |
| US-5185327-A | Glucan derivatives having tumoricidal activity | AJINOMOTO COMPANY, INC. (JP) | 1993-02-09 | — | — | US | claimed |
| EP-0475383-A2 | Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient | NISSHINBO INDUSTRIES, INC. (JP) | 1992-03-18 | — | — | EP | claimed |
| US-4973581-A | GALACTOPYANOSE OR ARABINOFURANOSE SIDE CHAIN | AJINOMOTO COMPANY, INC. (JP) | 1990-11-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030060622-A1 | Process for the preparation of 2'-halo-beta-L-arabinofuranosyl nucleosides | FUCA2, FUCA1, GALE | LGALS1 426/4885LGALS3 388/4885LGALS9 285/4885 |
| US-20040063612-A1 | Neuroprotective agents | GAP43, NLN, NOS3 | LGALS1 2328/4885LGALS3 1892/4885LGALS9 2729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.